Article
Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy.
Journal of viral hepatitis - 1 Dec 2018
Hayashi Kazuhiko, Ishigami Masatoshi, Ishizu Yoji, Kuzuya Teiji, Honda Takashi, Hirooka Yoshiki, Toyoda Hidenori, Kumada Takashi, Hattori Masashi, Katano Yoshiaki, Goto Hidemi
Abstract excerpt
The optimal term of follow-up for patients who achieve sustained virological responses (SVR) is an important topic because of the widespread use of direct-acting antivirals (DAA), which achieve a high SVR rate. Investigations of long-term follow-up among patients with SVR after interferon (IFN) therapy have reported that approximately 80%-100% of patients maintained SVR. However, the long-term durability of SVR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.